发明名称 2-morpholino-4-pyrimidone compound
摘要 A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein X represents CH or N; R 1 represents a C 1 -C 12 alkyl; R 2 represents a hydrogen atom, or the like; R' represents a C 1 -C 6 alkyl or the like; q represents 0 or an integer of 1 to 7; Y represents a C 1 -C 6 alkyl or the like; p represents 0 or an integer of 1 to 5; R represents a 2,3-dihydroindolyl or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).
申请公布号 ZA200702266(B) 申请公布日期 2008.09.25
申请号 ZA20070002266 申请日期 2005.09.09
申请人 MITSUBISHI PHARMA CORPORATION;SANOFI-AVENTIS 发明人 WATANABE, KAZUTOSHI;UEHARA, FUMIAKI;HIKI, SHINSUKE;KOHARA, TOSHIYUKI;FUKUNAGA, KENJI;YOKOSHIMA, SATOSHI
分类号 A61K;A61P;C07D 主分类号 A61K
代理机构 代理人
主权项
地址